A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif®) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis
Mikol, D, Lopez-Bresnahan, M, Taraskiewicz, S, Chang, P, Rangnow, J
Published in Multiple sclerosis (01.10.2005)
Published in Multiple sclerosis (01.10.2005)
Get full text
Journal Article
A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-la (Rebif®) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis
MIKOL, D, LOPEZ-BRESNAHAN, M, TARASKIEWICZ, S, CHANG, P, RANGNOW, J
Published in Multiple sclerosis (2005)
Get full text
Published in Multiple sclerosis (2005)
Journal Article